Veli YAZISIZ, et al. “Onset of Inflammatory Bowel Disease Following Interleukin-17A Inhibitor Treatment”. Archives of Rheumatology, vol. 35, no. 2, June 2020, pp. 300-2, doi:10.46497/ArchRheumatol.2020.7555.